| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate |
2003-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7416f1a440e2ca3877c90bcd4817dd16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc437714fe92786c1cb5c621de78ce50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb722fd3cb24ba04c188b0ae2fe2fbb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9059bd162287aa4042317bc335f929df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0c984645000b90b1a55061b327a652f |
| publicationDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004038950-A1 |
| titleOfInvention |
Pharmaceutical composition for treating IL-1 related diseases or disorders |
| abstract |
The present invention relates to a pharmaceutical composition for treating (IL-1)-related disease or disorder, which comprises: (a) a therapeutically effective dose of dehyroepiandrosterone or its derivative represented by the formula (I); and (b) a pharmaceutically acceptable carrier: n n n wherein X is H, n n n R 1 is H or —NH 2 ; R 2 is H, —COOH, —NH 2 or n n n Ar is unsubstituted or substituted phenyl; and n is an integer of 1-20. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106187819-A |
| priorityDate |
2002-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |